Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Free Cash Flow (2024 - 2025)

Silence Therapeutics' Free Cash Flow history spans 2 years, with the latest figure at -$17.3 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 37.29% year-over-year to -$17.3 million; the TTM value through Dec 2025 reached -$62.3 million, up 8.14%, while the annual FY2025 figure was -$62.3 million, 8.14% up from the prior year.
  • Free Cash Flow for Q4 2025 was -$17.3 million at Silence Therapeutics, down from -$10.9 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$5.5 million in Q2 2024 and bottomed at -$27.5 million in Q4 2024.